The subgroup analysis in the PARADIGM-HF study reported pronounced changes in the N-terminal pro B-type natriuretic peptide (NT-proBNP) level with early switch to sacubitril/valsartan from enalapril [12,13]. The gene discussed is NPPB; the disease is hydrops fetalis.